This is a routine proxy filing with no material financial news. Traders should monitor the meeting outcome for the equity plan amendment, which could signal future equity grants. No immediate trading catalyst.
Price Chart
Executive Summary
Definium Therapeutics filed definitive additional proxy materials for its 2026 Annual General and Special Meeting to be held virtually on June 11, 2026. Shareholders will vote on the election of seven directors, ratification of KPMG as auditor, and an amendment to the 2025 Equity Incentive Plan to increase authorized shares by 5,000,000. The board recommends a 'For' vote on all proposals.
Key Facts
- Meeting date: June 11, 2026, virtual at www.virtualshareholdermeeting.com/DFTX2026
- Proposal 1: Election of 7 director nominees (Robert Barrow, Suzanne Bruhn, Roger Crystal, David Gryska, Andreas Krebs, Carol Vallone, Roger Adsett)
- Proposal 2: Ratification of KPMG LLP as independent auditor
- Proposal 3: Amendment to the 2025 Equity Incentive Plan to increase shares by 5,000,000
- Board recommends a 'For' vote on all proposals
- Shareholders must vote by June 10, 2026 at 11:59 PM ET
Financial Impact
Potential dilution from 5,000,000 additional shares under the equity incentive plan; no current share count or dilution percentage disclosed.
Risk Factors
- No material risks identified; standard governance proposals.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-182066 |
| Document: 0001193125-26-182066-index-headers.html | 0001193125-26-182066 |
| Document: 0001193125-26-182066-index.html | 0001193125-26-182066 |
| Document: 0001193125-26-182066.txt | 0001193125-26-182066 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 18d ago | 8-K | $40.25 $39.28 | ▼ −2.41% | ▼ −2.52% | $37.40 (−7.08%) |
Aug 12, 2026 7w ago | 8-K | $42.79 $45.82 | ▲ +7.08% | ▲ +7.53% | $37.40 (−12.60%) |
Aug 9, 2026 7w ago | Institutional Cluster | $45.15 $45.26 | ▲ +0.24% | ▲ +0.29% | $37.40 (−17.17%) |
Jun 25, 2026 14w ago | 144 | $44.95 $44.19 | ▼ −1.69% | ▼ −3.86% | $37.40 (−16.80%) |
Jun 25, 2026 14w ago | 144 | $44.95 $44.19 | ▼ −1.69% | ▼ −3.86% | $37.40 (−16.80%) |
Jun 24, 2026 14w ago | 8-K | $44.79 $43.40 | ▲ +3.10% | ▲ +4.66% | $37.40 (+16.50%) |
Jun 24, 2026 14w ago | 424B5 | $44.79 $43.40 | ▲ +3.10% | ▲ +4.66% | $37.40 (+16.50%) |
Jun 22, 2026 14w ago | 424B5 | $36.18 $46.55 | ▼ −28.66% | ▼ −27.65% | $37.40 (−3.37%) |
Apr 27, 2026 22w ago | DEFA14A | $21.27 $21.75 | ▲ +2.26% | ▲ +0.56% | $37.40 (+75.83%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access